[1] Cascella M, Rajnik M, Cuomo A, Dulebohn SC, Di Napoli R. Features, Evaluation, and Treatment of Coronavirus. 2020.
[2] Berenguer J, Ryan P, Rodríguez-Baño J, Jarrín I, Carratalà J, Pachón J, et al. Characteristics and predictors of death among 4035 consecutively hospitalized patients with COVID-19 in Spain. Clin Microbiol Infect 2020;26:1525–36. https://doi.org/10.1016/j.cmi.2020.07.024.
[3] Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 2020;395:1054–62. https://doi.org/10.1016/S0140-6736(20)30566-3.
[4] Bonetti G, Manelli F, Patroni A, Bettinardi A, Borrelli G, Fiordalisi G, et al. Laboratory predictors of death from coronavirus disease 2019 (COVID-19) in the area of Valcamonica, Italy. Clin Chem Lab Med 2020;58:1100–5. https://doi.org/10.1515/cclm-2020-0459.
[5] Van Dam PMEL, Zelis N, Stassen P, Van Twist DJL, De Leeuw PW, Van Kuijk S, et al. Validating the RISE up score for predicting prognosis in patients with COVID-19 in the emergency department: A retrospective study. BMJ Open 2021;11:45141. https://doi.org/10.1136/bmjopen-2020-045141.
[6] Gupta RK, Harrison EM, Ho A, Docherty AB, Knight SR, van Smeden M, et al. Development and validation of the ISARIC 4C Deterioration model for adults hospitalised with COVID-19: a prospective cohort study. Lancet Respir Med 2021;9:349–59. https://doi.org/10.1016/S2213-2600(20)30559-2.
[7] Wynants L, Van Calster B, Collins GS, Riley RD, Heinze G, Schuit E, et al. Prediction models for diagnosis and prognosis of covid-19: Systematic review and critical appraisal. BMJ 2020;369:26. https://doi.org/10.1136/bmj.m1328.
[8] On NHC& SA of TCM. Diagnosis and Treatment Protocol for Novel Coronavirus Pneumoniae. (trial version 7). 2020.
[9] Team RC. R: A language and environment for statistical computingitle 2017.
[10] Karagiannidis C, Mostert C, Hentschker C, Voshaar T, Malzahn J, Schillinger G, et al. Case characteristics, resource use, and outcomes of 10 021 patients with COVID-19 admitted to 920 German hospitals: an observational study. Lancet Respir Med 2020;8:853–62. https://doi.org/10.1016/S2213-2600(20)30316-7.
[11] Zaim S, Chong JH, Sankaranarayanan V, Harky A. COVID-19 and Multiorgan Response. Curr Probl Cardiol 2020;45. https://doi.org/10.1016/j.cpcardiol.2020.100618.
[12] Lazzaroni MG, Piantoni S, Masneri S, Garrafa E, Martini G, Tincani A, et al. Coagulation dysfunction in COVID-19: The interplay between inflammation, viral infection and the coagulation system. Blood Rev 2021;46. https://doi.org/10.1016/j.blre.2020.100745.
[13] Qin C, Zhou L, Hu Z, Zhang S, Yang S, Tao Y, et al. Dysregulation of immune response in patients with coronavirus 2019 (COVID-19) in Wuhan, China. Clin Infect Dis 2020;71:762–8. https://doi.org/10.1093/cid/ciaa248.
[14] Li H, Liu L, Zhang D, Xu J, Dai H, Tang N, et al. SARS-CoV-2 and viral sepsis: observations and hypotheses. Lancet 2020;395:1517–20. https://doi.org/10.1016/S0140-6736(20)30920-X.
[15] Rubsamen R, Burkholz S, Massey C, Brasel T, Hodge T, Wang L, et al. Anti-IL-6 Versus Anti-IL-6R Blocking Antibodies to Treat Acute Ebola Infection in BALB/c Mice: Potential Implications for Treating Cytokine Release Syndrome. Front Pharmacol 2020;11. https://doi.org/10.3389/fphar.2020.574703.
[16] Frank K, Paust S. Dynamic Natural Killer Cell and T Cell Responses to Influenza Infection. Front Cell Infect Microbiol 2020;10:425. https://doi.org/10.3389/fcimb.2020.00425.
[17] Tang Y, Liu J, Zhang D, Xu Z, Ji J, Wen C. Cytokine Storm in COVID-19: The Current Evidence and Treatment Strategies. Front Immunol 2020;11:1708. https://doi.org/10.3389/fimmu.2020.01708.
[18] Du RH, Liang LR, Yang CQ, Wang W, Cao TZ, Li M, et al. Predictors of mortality for patients with COVID-19 pneumonia caused by SARSCoV- 2: A prospective cohort study. Eur Respir J 2020;55. https://doi.org/10.1183/13993003.00524-2020.
[19] Zhu Z, Cai T, Fan L, Lou K, Hua X, Huang Z, et al. Clinical value of immune-inflammatory parameters to assess the severity of coronavirus disease 2019. Int J Infect Dis 2020;95:332–9. https://doi.org/10.1016/j.ijid.2020.04.041.
[20] Mare TA, Treacher DF, Shankar-Hari M, Beale R, Lewis SM, Chambers DJ, et al. The diagnostic and prognostic significance of monitoring blood levels of immature neutrophils in patients with systemic inflammation. Crit Care 2015;19. https://doi.org/10.1186/s13054-015-0778-z.
[21] Schulte-Schrepping J, Reusch N, Paclik D, Baßler K, Schlickeiser S, Zhang B, et al. Severe COVID-19 Is Marked by a Dysregulated Myeloid Cell Compartment. Cell 2020;182:1419-1440.e23. https://doi.org/10.1016/j.cell.2020.08.001.
[22] Schulte-Schrepping J, Reusch N, Paclik D, Baßler K, Schlickeiser S, Zhang B, et al. Suppressive myeloid cells are a hallmark of severe COVID-19. MedRxiv 2020;19:2020.06.03.20119818. https://doi.org/10.1101/2020.06.03.20119818.
[23] Carissimo G, Xu W, Kwok I, Abdad MY, Chan YH, Fong SW, et al. Whole blood immunophenotyping uncovers immature neutrophil-to-VD2 T-cell ratio as an early marker for severe COVID-19. Nat Commun 2020;11:1–12. https://doi.org/10.1038/s41467-020-19080-6.
[24] Zini G, Bellesi S, Ramundo F, d’Onofrio G. Morphological anomalies of circulating blood cells in <scp>COVID</scp> ‐19. Am J Hematol 2020;95:870–2. https://doi.org/10.1002/ajh.25824.
[25] Bronte V, Zanovello P. Regulation of immune responses by L-arginine metabolism. Nat Rev Immunol 2005;5:641–54. https://doi.org/10.1038/nri1668.
[26] Linssen J, Ermens A, Berrevoets M, Seghezzi M, Previtali G, Brugge S van der S van der, et al. A novel haemocytometric covid-19 prognostic score developed and validated in an observational multicentre european hospital-based study. Elife 2020;9:1–37. https://doi.org/10.7554/eLife.63195.
[27] Babapoor-Farrokhran S, Gill D, Walker J, Rasekhi RT, Bozorgnia B, Amanullah A. Myocardial injury and COVID-19: Possible mechanisms. Life Sci 2020;253. https://doi.org/10.1016/j.lfs.2020.117723.
[28] Shi W, Lv J, Lin L. Coagulopathy in COVID-19: Focus on vascular thrombotic events. J Mol Cell Cardiol 2020;146:32–40. https://doi.org/10.1016/j.yjmcc.2020.07.003.
[29] Opoka-Winiarska V, Grywalska E, Roliński J. Could hemophagocytic lymphohistiocytosis be the core issue of severe COVID-19 cases? BMC Med 2020;18. https://doi.org/10.1186/s12916-020-01682-y.